# Novo Nordisk US Bio Production Inc. – FDA Inspection, Jul 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/7ff90033-28ae-475d-a08e-04d19cc180a1
Source feed: FDA_Inspections

> FDA inspection 1214482 of Novo Nordisk US Bio Production Inc., July 25, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214482
- Company Name: Novo Nordisk US Bio Production Inc.
- Inspection Date: 2023-07-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1292060 - 2025-12-09](https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/b0077115-b9ef-46ae-81a7-75debc87bcbd)
- FDA Inspection 1255809 - 2025-03-05
- [FDA Inspection 1064794 - 2018-08-24](https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/ef10d29d-5777-4d7d-94bd-d1f7c5119948)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/novo-nordisk-us-bio-production-inc/08f5214b-4db0-4d94-86ee-4ba9c3c28ea2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
